Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

SpineGuard Validates Results of New Ultrasonic Technology

French company SpineGuard announces the successful defense of a doctoral thesis presenting the results obtained with a robot-assisted ultrasonic technology intended for spinal surgery. This innovation complements the group's existing DSG technology.


SpineGuard Validates Results of New Ultrasonic Technology

Successful Thesis Defense

Jorge Andrés Pérez Velásquez, a doctoral engineering student at SpineGuard, successfully defended his thesis on December 11 in Paris, the company reports. The presented work focuses on a robotically assisted ultrasonic technology that determines the entry point and pedicular trajectory from the bone surface of the spine. According to the group, this defense marks the second validation by the scientific community of the feasibility of this innovation, following a presentation at the CFA congress last April.

Enhancement of Existing Technology

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The new ultrasonic technology, patented by SpineGuard, complements the company's existing DSG technology, the statement specifies. It enables the determination of the entry point and drilling direction from the posterior surface of the bone without the use of X-rays, before the DSG-equipped drill penetrates the bone. According to Stéphane Bette, deputy CEO and co-founder of SpineGuard, secure drilling with automatic breach detection has already been validated by previously published works.

Collaboration and Future Steps

These results stem from the collaboration between SpineGuard and Sorbonne University, the group emphasizes. The company indicates that the next step involves seeking an industrial partner to exploit this technology. SpineGuard notes that more than 110,000 surgeries have been secured to date using its DSG technology, whose reliability and precision have been established by 39 studies published in leading medical journals.



Sector Santé · Equipements médicaux Équipements Médicaux


Assurance vie

Context

Period
  • Period: Résultats annuels 2025
Key reported figures
  • Revenue: 3 757 K€
  • Net income: -2 068 K€
Guidance from the release
  • La direction met en évidence la forte amélioration des résultats financiers en 2025, fruit de la transformation progressive du modèle commercial, notamment aux États?Unis, et de l'engagement des équipes.
  • Résultats annuels 2025 : chiffre d'affaires de 3 757 K€, marge brute de 78,9 %, amélioration du résultat opérationnel courant à -1 660 K€ et du résultat net à -2 068 K€. Le premier trimestre 2026 affiche un chiffre d'affaires de 820 K€, avec une dynamique divergent selon les marchés (États-Unis en baisse, Europe et Moyen-Orient en croissance) et l'annonce d'un financement obligataire maximal d'un million d'euros. Le groupe prévoit d'atteindre l'équilibre opérationnel d'ici fin 2026 et de couvrir les besoins de financement jusqu'au deuxième trimestre 2027.
Outlook / guidance
  • Management commentary: L'entreprise prévoit d'atteindre l'équilibre opérationnel d'ici la fin de l'année 2026 et de couvrir les besoins de financement jusqu'au 2e trimestre 2027.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit